NCT03761082View on ClinicalTrials.gov

Post Marketing Surveillance of PIRESPA® TAB 200mg (Pirfenidone) for Evaluating the Safety and Efficacy

CompletedOBSERVATIONAL
Enrollment

258

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
OTHER

NA(observation study)

NA(observation study)

Sponsors
All Listed Sponsors
lead

IlDong Pharmaceutical Co Ltd

INDUSTRY

NCT03761082 - Post Marketing Surveillance of PIRESPA® TAB 200mg (Pirfenidone) for Evaluating the Safety and Efficacy | Biotech Hunter | Biotech Hunter